Mirtazapine exposure in pregnancy and fetal safety: A nationwide cohort study-Reference-Cited by-同舟云学术

Mirtazapine exposure in pregnancy and fetal safety: A nationwide cohort study

Published:2022-04 Issue:6 Volume:145 Page:557-567
ISSN:0001-690X
Container-title:Acta Psychiatrica Scandinavica
language:en
Short-container-title:Acta Psychiatr Scand

Author:

Ostenfeld Anne¹²^ORCID,Petersen Tonny Studsgaard²³,Pedersen Lars Henning⁴⁵⁶,Westergaard Hanne Brix¹²,Løkkegaard Ellen Christine Leth¹²,Andersen Jon Trærup²³

Affiliation:

1. Department of Obstetrics and Gynaecology Copenhagen University Hospital Nordsjællands Hospital Hillerød Denmark

2. Department of Clinical Medicine University of Copenhagen Copenhagen Denmark

3. Department of Clinical Pharmacology Bispebjerg and Frederiksberg Hospital Copenhagen University Hospital Copenhagen Denmark

4. Department of Obstetrics and Gynaecology Aarhus University Hospital Aarhus Denmark

5. Department of Clinical Medicine Aarhus University Aarhus Denmark

6. Department of Biomedicine Aarhus University Aarhus Denmark

Funder

Kong Christian den Tiendes Fond

Publisher

Wiley

Subject

Psychiatry and Mental health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/acps.13431

Reference26 articles.

1. A systematic review and meta-regression of the prevalence and incidence of perinatal depression

2. Untreated depression during pregnancy: Short- and long-term effects in offspring. A systematic review

3. Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines

4. Review of the use of mirtazapine in the treatment of depression

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antidepressants and fetal death: A systematic review and disproportionality analysis in the WHO safety database (VigiBaseⓇ);Psychiatry Research;2024-09

2. Mirtazapine in pregnancy and lactation: A systematic review of adverse outcomes;Acta Psychiatrica Scandinavica;2024-08-31

3. The use of psychotropic medication in the perinatal period;The Obstetrician & Gynaecologist;2024-06-18

4. Risk of Congenital Anomalies Associated with Psychotropic Medications: A Review of Neonatal Reports in the FDA Adverse Event Reporting System (FAERS);2024-05-13

5. Depression Treatment in Pregnancy: Is It Safe, or Is It Not?;International Journal of Environmental Research and Public Health;2024-03-26